Litigation Details for Pernix Ireland Pain DAC v. Alvogen Malta Operations Ltd. (D. Del. 2016)
✉ Email this page to a colleague
Pernix Ireland Pain DAC v. Alvogen Malta Operations Ltd. (D. Del. 2016)
| Docket | ⤷ Sign Up | Date Filed | 2016-03-04 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:0145 | Assigned To | Gregory Moneta Sleet |
| Jury Demand | None | Referred To | |
| Patents | 8,808,740; 9,265,760; 9,339,499 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Pernix Ireland Pain DAC v. Alvogen Malta Operations Ltd.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Pernix Ireland Pain DAC v. Alvogen Malta Operations Ltd. (D. Del. 2016)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2018-05-15 | 216 | Opinion - Memorandum Opinion | references, U.S. Patent Appl. No. 2006/0240105 (“Devane”) and U.S. Patent No. 8,808,740 (“Huang”). …Pernix’s U.S. Patent No. 9,265,760 (“the ’760 patent”), and claim 1 of Pernix’s U.S. Patent No. 9,339,499…,499 (“the ’499 patent”). Pernix’s patents are directed to methods of treating pain in patients with …patients’ systems. See ’760 patent, col. 2, ll. 41–66. The patented invention encompasses formulations…claims 12, 17, and 19 of the ’760 patent, and claim 1 of the ’499 patent, are likewise directed to methods | External link to document |
| 2018-06-08 | 236 | Order | reports to challenge Alvogen’s claim that U.S. Patent No. 8,808,740 to Huang is an invalidating prior art reference…party admissions is an issue that is not unique to patent law, Third Circuit law—not Federal Circuit law—…Fed. Cir. 2014) (merits of evidentiary rulings in patent cases reviewed under regional circuit law). As… 4 March 2016 1:16-cv-00139-WCB Patent None District Court, D. Delaware | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
